{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:33:05Z","timestamp":1777516385516,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03499-0","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T10:01:34Z","timestamp":1716458494000},"page":"3013-3019","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The value of combined MRI, enhanced CT and 18F-FDG PET\/CT in the diagnosis of recurrence and metastasis after surgery for ovarian cancer"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6971-6659","authenticated-orcid":false,"given":"Yong","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanni","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuewen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"3499_CR1","doi-asserted-by":"crossref","unstructured":"Tossetta G, Inversetti A. Ovarian cancer: advances in pathophysiology and therapies. Int J Mol Sci. 2023;24(10).","DOI":"10.3390\/ijms24108930"},{"issue":"11","key":"3499_CR2","first-page":"937","volume":"93","author":"CA Doubeni","year":"2016","unstructured":"Doubeni CA, Doubeni AR, Myers AE. Diagnosis and management of ovarian cancer. Am Fam Physician. 2016;93(11):937\u201344.","journal-title":"Am Fam Physician"},{"issue":"1","key":"3499_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12885-023-10737-1","volume":"23","author":"S Liu","year":"2023","unstructured":"Liu S, Feng S, Du F, Zhang K, Shen Y. Association of smoking, alcohol, and coffee consumption with the risk of ovarian cancer and prognosis: a mendelian randomization study. BMC Cancer. 2023;23(1):256.","journal-title":"BMC Cancer"},{"issue":"5","key":"3499_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/AOG.0000000000002580","volume":"131","author":"U Menon","year":"2018","unstructured":"Menon U, Karpinskyj C, Gentry-Maharaj A. Ovarian cancer prevention and screening. Obstet Gynecol. 2018;131(5):909\u201327.","journal-title":"Obstet Gynecol"},{"key":"3499_CR5","doi-asserted-by":"crossref","unstructured":"Pogge von Strandmann E, Reinartz S, Wager U, Muller R. Tumor-host cell interactions in ovarian cancer: pathways to therapy failure. Trends Cancer. 2017;3(2):137\u2013148.","DOI":"10.1016\/j.trecan.2016.12.005"},{"key":"3499_CR6","doi-asserted-by":"crossref","unstructured":"Nougaret S, Tardieu M, Vargas HA, Reinhold C, Vande Perre S, Bonanno N, et al. Ovarian cancer: an update on imaging in the era of radiomics. Diagn Interv Imaging. 2019;100(10):647\u2013655.","DOI":"10.1016\/j.diii.2018.11.007"},{"issue":"10","key":"3499_CR7","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1007\/s00330-020-06937-z","volume":"30","author":"R Forstner","year":"2020","unstructured":"Forstner R. Early detection of ovarian cancer. Eur Radiol. 2020;30(10):5370\u20133.","journal-title":"Eur Radiol"},{"issue":"12","key":"3499_CR8","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1007\/s00330-007-0736-5","volume":"17","author":"R Forstner","year":"2007","unstructured":"Forstner R. Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur Radiol. 2007;17(12):3223\u201335.","journal-title":"Eur Radiol"},{"key":"3499_CR9","doi-asserted-by":"crossref","unstructured":"Sohaib SA, Reznek RH. MR imaging in ovarian cancer. Cancer Imaging. 2007;7 Spec No A(Special issue A):S119\u201329.","DOI":"10.1102\/1470-7330.2007.9046"},{"issue":"6","key":"3499_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1053\/j.semnuclmed.2021.06.006","volume":"51","author":"D Dejanovic","year":"2021","unstructured":"Dejanovic D, Hansen NL, Loft A. PET\/CT variants and pitfalls in gynecological cancers. Semin Nucl Med. 2021;51(6):593\u2013610.","journal-title":"Semin Nucl Med"},{"key":"3499_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5603\/NMR.2023.0013","volume":"26","author":"M Kosinska","year":"2023","unstructured":"Kosinska M, Misiewicz P, Kalita K, Fijuth J, Foks M, Kuncman L, et al. The value of [18F]FDG PET\/CT examination in the detection and differentiation of recurrent ovarian cancer. Nucl Med Rev Cent East Eur. 2023;26:98\u2013105.","journal-title":"Nucl Med Rev Cent East Eur"},{"issue":"5","key":"3499_CR12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.rcl.2021.05.011","volume":"59","author":"SN Friedman","year":"2021","unstructured":"Friedman SN, Itani M, Dehdashti F. PET imaging for gynecologic malignancies. Radiol Clin North Am. 2021;59(5):813\u201333.","journal-title":"Radiol Clin North Am"},{"issue":"9","key":"3499_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","volume":"4","author":"PA Konstantinopoulos","year":"2023","unstructured":"Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nat Cancer. 2023;4(9):1239\u201357.","journal-title":"Nat Cancer"},{"issue":"3","key":"3499_CR14","first-page":"351","volume":"36","author":"N Izycka","year":"2015","unstructured":"Izycka N, Lubin J, Markowska A, Markowska J. Late recurrence of ovarian cancer: a literature review and description of two cases. Eur J Gynaecol Oncol. 2015;36(3):351\u20133.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"2","key":"3499_CR15","first-page":"93","volume":"60","author":"P Mapelli","year":"2016","unstructured":"Mapelli P, Incerti E, Fallanca F, Gianolli L, Picchio M. Imaging biomarkers in ovarian cancer: the role of (1)(8)F-FDG PET\/CT. Q J Nucl Med Mol Imaging. 2016;60(2):93\u2013102.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"6","key":"3499_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/j.semnuclmed.2019.06.010","volume":"49","author":"J Kemppainen","year":"2019","unstructured":"Kemppainen J, Hynninen J, Virtanen J, Seppanen M. PET\/CT for evaluation of ovarian cancer. Semin Nucl Med. 2019;49(6):484\u201392.","journal-title":"Semin Nucl Med"},{"issue":"2","key":"3499_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2214\/AJR.09.3522","volume":"194","author":"VR Iyer","year":"2010","unstructured":"Iyer VR, Lee SI. MRI, CT, and PET\/CT for ovarian cancer detection and adnexal lesion characterization. AJR Am J Roentgenol. 2010;194(2):311\u201321.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"3499_CR18","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1007\/s00261-020-02820-z","volume":"46","author":"S Nougaret","year":"2021","unstructured":"Nougaret S, McCague C, Tibermacine H, Vargas HA, Rizzo S, Sala E. Radiomics and radiogenomics in ovarian cancer: a literature review. Abdom Radiol (NY). 2021;46(6):2308\u201322.","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"3499_CR19","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.ejrad.2011.01.112","volume":"81","author":"Y Yuan","year":"2012","unstructured":"Yuan Y, Gu ZX, Tao XF, Liu SY. Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: a meta-analysis. Eur J Radiol. 2012;81(5):1002\u20136.","journal-title":"Eur J Radiol"},{"issue":"4","key":"3499_CR20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.21873\/anticanres.14180","volume":"40","author":"A Gadducci","year":"2020","unstructured":"Gadducci A, Simonetti E, Manca G, Guidoccio F, Fanucchi A, Cosio S, et al. Positron emission tomography\/computed tomography in platinum-sensitive recurrent ovarian cancer: a single-center Italian Study. Anticancer Res. 2020;40(4):2191\u20137.","journal-title":"Anticancer Res"},{"issue":"3","key":"3499_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12149-010-0449-8","volume":"25","author":"K Kitajima","year":"2011","unstructured":"Kitajima K, Murakami K, Sakamoto S, Kaji Y, Sugimura K. Present and future of FDG-PET\/CT in ovarian cancer. Ann Nucl Med. 2011;25(3):155\u201364.","journal-title":"Ann Nucl Med"},{"issue":"2","key":"3499_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1148\/rg.312105713","volume":"31","author":"H Son","year":"2011","unstructured":"Son H, Khan SM, Rahaman J, Cameron KL, Prasad-Hayes M, Chuang L, et al. Role of FDG PET\/CT in staging of recurrent ovarian cancer. Radiographics. 2011;31(2):569\u201383.","journal-title":"Radiographics"},{"issue":"1079","key":"3499_CR23","doi-asserted-by":"publisher","first-page":"20170283","DOI":"10.1259\/bjr.20170283","volume":"90","author":"P Narayanan","year":"2017","unstructured":"Narayanan P, Sahdev A. The role of (18)F-FDG PET CT in common gynaecological malignancies. Br J Radiol. 2017;90(1079):20170283.","journal-title":"Br J Radiol"},{"issue":"4\u20135","key":"3499_CR24","first-page":"167","volume":"8","author":"E Nowosinska","year":"2010","unstructured":"Nowosinska E, Avril S, Murray I, Szyszko T, Avril N. FDG-PET\/CT as a molecular biomarker in ovarian cancer. Cancer Biomark. 2010;8(4\u20135):167\u201375.","journal-title":"Cancer Biomark"},{"issue":"13","key":"3499_CR25","first-page":"7276","volume":"24","author":"J Sun","year":"2020","unstructured":"Sun J, Cui XW, Li YS, Wang SY, Yin Q, Wang XN, et al. The value of 18F-FDG PET\/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer. Eur Rev Med Pharmacol Sci. 2020;24(13):7276\u201383.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"3499_CR26","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00404-010-1568-0","volume":"283","author":"K Nasu","year":"2011","unstructured":"Nasu K, Abe W, Takai N, Tomonari K, Narahara H. Impact of positron emission tomography\/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment. Arch Gynecol Obstet. 2011;283(5):1121\u20136.","journal-title":"Arch Gynecol Obstet"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03499-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03499-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03499-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:37:38Z","timestamp":1731587858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03499-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3499"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03499-0","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"17 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was ratified by the ethic committee of Huadu District People\u2019s Hospital of Guangzhou (approval number: 20191012). Written informed consent was acquired from all the subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was acquired from all the subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}